GNLX Genelux Corporation
Healthcare$3.01+3.08%ClosedMarket Cap: $113.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.14
P/S
13730.17
EV/EBITDA
-3.10
DCF Value
$0.10
FCF Yield
-25.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
-3550.0%
Operating Margin
-422037.5%
Net Margin
-397225.0%
ROE
-165.2%
ROA
-98.2%
ROIC
-132.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-8.4M | $-7.1M | $— | — |
| Q4 null | $8.0K | -1750.0% | $-9.4M | $-9.2M | $— | — |
| FY null | $8.0K | -7075.0% | $-33.2M | $-32.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-8.2M | $-8.0M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-7.8M | $-7.5M | $— | — |
| Q1 null | $0.00 | NaN% | $-7.8M | $-7.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-9.7M | $-9.0M | $— | — |
| FY null | $8.0K | -11187.5% | $-31.7M | $-29.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-6.9M | $-6.5M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-6.9M | $-6.6M | $— | — |
| Q1 null | $8.0K | -3000.0% | $-8.1M | $-7.8M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-7.0M | $-6.8M | $-0.25 | — |